{
  "id": 8984066,
  "title": "Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016",
  "url": "https://urgent.news/2026/09/21/eli-lilly-stock-is-on-track-to-do-something-it-hasnt-done-since-2016",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-21T17:44:26.000Z",
  "source": {
    "name": "Motley Fool",
    "slug": "motley-fool",
    "url": "https://www.fool.com/investing/2026/09/21/eli-lilly-stock-is-on-track-to-do-something-it-hasn-t-done-since-2016/?source=iedfolrf0000001"
  },
  "original_language": "en",
  "account": null,
  "summary": "The top healthcare stock has been underperforming the market, and its returns haven't been as impressive as in recent years.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Nasdaq Markets",
        "title": "Eli Lilly Stock Is On Track to Do Something It Hasn't Done Since 2016",
        "url": "https://urgent.news/2026/09/21/eli-lilly-stock-is-on-track-to-do-something-it-hasnt-done-since-2016-8984838",
        "published": "2026-09-21T18:04:26.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}